Cantel Medical (CMD) Misses Q2 EPS by 6c

Cantel Medical (NYSE: CMD) reported Q2 EPS of $0.61, $0.06 worse than the analyst estimate of $0.67. Revenue for the quarter came in at $288.5 million versus the consensus estimate of $290.45 million.

For earnings history and earnings-related data on Cantel Medical (CMD) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c